Literature DB >> 32338497

Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway In Vivo.

Anvesh K R Dasari1, Ivan Hung2, Brian Michael3, Zhehong Gan2, Jeffery W Kelly4, Lawreen H Connors5, Robert G Griffin3, Kwang Hun Lim1.   

Abstract

Structural characterization of misfolded protein aggregates is essential to understanding the molecular mechanism of protein aggregation associated with various protein misfolding disorders. Here, we report structural analyses of ex vivo transthyretin aggregates extracted from human cardiac tissue. Comparative structural analyses of in vitro and ex vivo transthyretin aggregates using various biophysical techniques revealed that cardiac transthyretin amyloid has structural features similar to those of in vitro transthyretin amyloid. Our solid-state nuclear magnetic resonance studies showed that in vitro amyloid contains extensive nativelike β-sheet structures, while other loop regions including helical structures are disrupted in the amyloid state. These results suggest that transthyretin undergoes a common misfolding and aggregation transition to nativelike aggregation-prone monomers that self-assemble into amyloid precipitates in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32338497      PMCID: PMC7306164          DOI: 10.1021/acs.biochem.0c00091

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils.

Authors:  Giorgia Zandomeneghi; Mark R H Krebs; Margaret G McCammon; Marcus Fändrich
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

Review 2.  Conformational change and assembly through edge beta strands in transthyretin and other amyloid proteins.

Authors:  Janel Laidman; G Jason Forse; Todd O Yeates
Journal:  Acc Chem Res       Date:  2006-09       Impact factor: 22.384

Review 3.  Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.

Authors:  Natalie J Galant; Per Westermark; Jeffrey N Higaki; Avijit Chakrabartty
Journal:  Clin Sci (Lond)       Date:  2017-03-01       Impact factor: 6.124

Review 4.  Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.

Authors:  David Adams; Haruki Koike; Michel Slama; Teresa Coelho
Journal:  Nat Rev Neurol       Date:  2019-06-17       Impact factor: 42.937

Review 5.  Transthyretin: the servant of many masters.

Authors:  Joel N Buxbaum; Natàlia Reixach
Journal:  Cell Mol Life Sci       Date:  2009-07-31       Impact factor: 9.261

6.  Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.

Authors:  H A Lashuel; Z Lai; J W Kelly
Journal:  Biochemistry       Date:  1998-12-22       Impact factor: 3.162

7.  Arrangement of subunits and ordering of beta-strands in an amyloid sheet.

Authors:  Ahmed A Serag; Christian Altenbach; Mari Gingery; Wayne L Hubbell; Todd O Yeates
Journal:  Nat Struct Biol       Date:  2002-10

8.  Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award.

Authors:  J Herbert; J N Wilcox; K T Pham; R T Fremeau; M Zeviani; A Dwork; D R Soprano; A Makover; D S Goodman; E A Zimmerman
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

9.  Tabulation of human transthyretin (TTR) variants, 2003.

Authors:  Lawreen Heller Connors; Amareth Lim; Tatiana Prokaeva; Violet A Roskens; Catherine E Costello
Journal:  Amyloid       Date:  2003-09       Impact factor: 7.141

10.  Uncovering the Mechanism of Aggregation of Human Transthyretin.

Authors:  Lorena Saelices; Lisa M Johnson; Wilson Y Liang; Michael R Sawaya; Duilio Cascio; Piotr Ruchala; Julian Whitelegge; Lin Jiang; Roland Riek; David S Eisenberg
Journal:  J Biol Chem       Date:  2015-10-12       Impact factor: 5.157

View more
  2 in total

1.  Thermodynamic Stability and Aggregation Kinetics of EF Helix and EF Loop Variants of Transthyretin.

Authors:  James A Ferguson; Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2021-03-01       Impact factor: 3.162

2.  Disruption of the CD Loop by Enzymatic Cleavage Promotes the Formation of Toxic Transthyretin Oligomers through a Common Transthyretin Misfolding Pathway.

Authors:  Anvesh K R Dasari; Jenette Arreola; Brian Michael; Robert G Griffin; Jeffery W Kelly; Kwang Hun Lim
Journal:  Biochemistry       Date:  2020-06-14       Impact factor: 3.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.